Inovio Pharmaceuticals Inc (NASDAQ:INO)

2.82
Delayed Data
As of Jul 22
 +0.03 / +1.08%
Today’s Change
2.15
Today|||52-Week Range
6.30
-29.50%
Year-to-Date
Inovio (INO) Ends Some Early-Stage R&D Programs, Cuts Jobs
Jul 17 / Zacks.com - Paid Partner Content
Inovio Ends Enrollment in Vulvar Dysplasia Study on VGX-3100
Jul 09 / Zacks.com - Paid Partner Content
Why Inovio Pharmaceuticals Stock Is Plunging Today
Jul 17 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close2.79
Today’s open2.80
Day’s range2.77 - 2.86
Volume443,444
Average volume (3 months)1,122,616
Market cap$274.0M
Data as of 4:00pm ET, 07/22/2019

Growth & Valuation

Earnings growth (last year)+2.98%
Earnings growth (this year)+5.53%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-27.80%
P/E ratioNM
Price/Sales12.14
Price/Book3.13

Competitors

 Today’s
change
Today’s
% change
VRCAVerrica Pharmaceutic...-0.24-2.32%
EIGREiger BioPharmaceuti...-0.03-0.28%
LOGCLogicBio Therapeutic...+0.33+2.60%
PHASPhaseBio Pharmaceuti...-0.23-2.29%
Data as of 4:00pm ET, 07/22/2019

Financials

Next reporting dateAugust 5, 2019
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$30.5M
Annual profit (last year)-$97.0M
Net profit margin-318.12%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
J. Joseph Kim
Chief Operating Officer &
Executive Vice President
Jacqueline E. Shea
Corporate headquarters
Plymouth Meeting, Pennsylvania

Forecasts